로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > EGF R

EGF R

요약

Name:Epidermal growth factor receptor erbB1
Target Synonym:Epidermal Growth Factor Receptor (Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog),Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian),Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog,Epidermal Growth Factor Receptor Tyrosine Kinase Domain,Cell Proliferation-Inducing Protein 61,Cell Growth Inhibiting Protein 40,EC 2.7.10.1,NISBD2,PIG61,MENA,EC:2.7.10.1,EC 2.7.10,Receptor tyrosine-protein kinase erbB-1,Proto-oncogene c-ErbB-1,Epidermal growth factor recep
Number of Launched Drugs:35
Number of Drugs in Clinical Trials:172
Lastest Research Phase:Approved

제품 리스트 비교 또는 구매

일부의 생물활성 데이터

EGR-H82E3-Cell-based assay
Evaluation of CAR expression

Cells were transfected with anti-EGFR scFv and cultured for 3 days. Three days post-transfection, 1e6 cells were stained for anti-EGFR scFv with Biotinylated Human EGFR, His,Avitag (Cat. No. EGR-H82E3) followed by PE-conjugated streptavidin. Flow Cytometry assay shows that Biotinylated Human EGFR, His,Avitag (Cat. No. EGR-H82E3) can bind to cells expressing anti-EGFR scFv. The concentration of EGFR used is 0.8 µg/mL. (Data are kindly provided by Guangzhou Bio-gene Technology Co. Ltd.)

EGR-H522a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Erbitux on CM5 Chip via anti-human Fc IgG, can bind Human EGF R, His Tag, low endotoxin (Cat.No. EGR-H522a) with an affinity constant of 0.492 nM as determined in SPR assay (Biacore T200) (Routinely tested).

EGR-H522a-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human EGF R, His Tag, low endotoxin (Cat. No. EGR-H522a) captured on CM5 Chip via anti-His antibody can bind Human EGF, Mouse IgG2a Fc Tag (Cat. No. EGF-H525b) with an affinity constant of 2.76 nM as determined in SPR assay (Biacore T200) (Routinely tested).

Synonym Name

EGFR,ERBB,ERBB1,HER1,PIG61,mENA

Background

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Mouse epidermal growth factor (Hangzhou Tianmushan Pharmaceutical) Approved Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd 一夫 Wounds and Injuries Details
Recombinant epidermal growth factor drop (Pavay Gene Pharmaceutical) Approved Guilin Huanuowei Gene Pharmaceutical Co Ltd 易贝 Mainland China Corneal Diseases Guilin Huanuowei Gene Pharmaceutical Co Ltd 2002-04-12 Corneal Diseases; Xerophthalmia Details
Recombinant epidermal growth factor (Shanghai Haohai ) Approved Shanghai Haohai Biological Technology Co Ltd 康合素 Mainland China Burns Shanghai Haohai Biological Technology Co Ltd 2001-01-01 Burns Details
Cetuximab biosimilar (CinnaGen) Approved Cinnagen Iran Colorectal Neoplasms Cinnagen 2017-01-01 Colorectal Neoplasms Details
Recombinant Human Epidermal Growth Factor Derivative Eye Drops (Shenzhen Wastin Genetech) Approved Shenzhen Watsin Genetech Ltd 金因舒, GeneSoft Mainland China Corneal Diseases Shenzhen Watsin Genetech Ltd 2004-01-21 Corneal Diseases Details
Recombinant human EGF conjugated vaccine Approved Biotech Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
Recombinant Human Epidermal Growth Factor Derivative (Shenzhen Wastin Genetech) rEGF Approved Shenzhen Watsin Genetech Ltd 金因肽, GeneTime Mainland China Wounds and Injuries Shenzhen Watsin Genetech Ltd 2001-01-01 Wounds and Injuries Details
Recombinant epidermal growth factor gel (Pavay Gene Pharmaceutical) Approved Guilin Huanuowei Gene Pharmaceutical Co Ltd 易孚 Mainland China Skin Ulcer; Burns Guilin Huanuowei Gene Pharmaceutical Co Ltd 2002-12-23 Skin Ulcer; Burns Details
Epidermal growth factor biosimilar (RAS Lifesciences) Approved Ras Lifesciences India Ras Lifesciences 2012-10-01 Details
Recombinant epidermal growth factor biosimilar (Elea) r-hu-EGF Approved Elea Argentina Diabetic Foot; Burns Elea 2015-01-01 Diabetic Foot; Burns Details
Recombinant epidermal growth factor (Bharat Biotech) REGEN-D 60; REGEN-D 150 Approved Bharat Biotech International Ltd India Diabetic Foot; Burns Bharat Biotech International Ltd 2005-01-01 Diabetic Foot; Burns Details
Recombinant epidermal growth factor (Center for Genetic Engineering and Biotechnology/Praxis Pharmaceuticals) Approved Praxis Pharmaceuticals, Center For Genetic Engineering And Biotechnology Heberprot-P Cuba Diabetic Foot null 2007-09-01 Diabetic Foot Details
PX-070101 PX-070101 Approved Praxis Pharmaceuticals Colombia Diabetic Foot Praxis Pharmaceuticals 2015-07-01 Diabetic Foot Details
Amivantamab JNJ-372; JNJ-61186372 Approved Janssen Global Services Llc, Genmab RYBREVANT Canada Carcinoma, Non-Small-Cell Lung Janssen Inc 2021-05-21 Carcinoma, Non-Small-Cell Lung Details
Panitumumab ABX-0303; E7.6.3; AMG-954; ABX-EGF; ABX-10221 Approved Amgen Inc Vectibix Japan Colorectal Neoplasms Takeda 2006-09-27 Colorectal Neoplasms Details
Necitumumab LY-3012211; IMC-11F8 Approved Eli Lilly And Company Portrazza Japan Carcinoma, Non-Small-Cell Lung Nippon Kayaku Co Ltd 2015-11-24 Carcinoma, Non-Small-Cell Lung Details
Icotinib Hydrochloride BPI-2009H; BPI-2009C Approved Betta Pharmaceuticals Co Ltd 凯美纳, Conmana Mainland China Carcinoma, Non-Small-Cell Lung Betta Pharmaceuticals Co Ltd 2011-06-07 Psoriasis; Carcinoma, Non-Small-Cell Lung Details
Cetuximab sarotalocan RM-1929; ASP-1929 Approved Aspyrian Therapeutics Akalux Japan Head and Neck Neoplasms Rakuten Medical 2020-09-25 Head and Neck Neoplasms Details
Olmutinib ZL-2303; HM-61713B; HM-61713; BI-1482694 Approved Hanmi Pharmaceutical Co Ltd Olita South Korea Carcinoma, Non-Small-Cell Lung Hanmi Pharmaceutical Co Ltd 2016-05-01 Carcinoma, Non-Small-Cell Lung Details
Vandetanib AZD-6474; CH-331; ZD-6474 Approved Astrazeneca Pharmaceutical Co Ltd Zactima, Caprelsa Japan Medullary thyroid cancer (MTC) Astrazeneca Pharmaceutical Co Ltd 2011-04-06 Thyroid Neoplasms; Paraganglioma; Adenocarcinoma; Precancerous Conditions; Neoplasm Metastasis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Glioma; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Neuroendocrine; Solid tumours; Colorectal Neoplasms; Pleural Effusion; Prostatic Neoplasms; Breast Neoplasms; Medullary thyroid cancer (MTC); Multiple Myeloma; Mesothelioma; Pheochromocytoma; Stomach Neoplasms; Esophageal Neoplasms Details
Dacomitinib PF-299; PF-804; PF-299804; PF-00299804; PF-00299804-3; PF-00299804-03 Approved Pfizer Inc Vizimpro Mainland China Carcinoma, Non-Small-Cell Lung Pfizer Europe Ma Eeig 2018-09-27 Head and Neck Neoplasms; Solid tumours; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Glioblastoma; Liver Diseases; Brain Neoplasms; Colorectal Neoplasms; Mouth Neoplasms; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Penile Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
Nepidermin DWP-401 Approved Daewoong Pharmaceutical Co Ltd Easyef Egypt Alopecia; Diabetic Foot Daewoong Pharmaceutical Co Ltd 2001-01-01 Diabetic Foot; Alopecia; Dry Eye Syndromes Details
Gefitinib ZD-1839 Approved Astrazeneca Pharmaceutical Co Ltd 易瑞沙, Iressa EU Carcinoma, Non-Small-Cell Lung Astrazeneca Ab 2002-07-05 Adrenocortical Carcinoma; Adenocarcinoma; Neoplasms, Germ Cell and Embryonal; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Brain metastases; Lung Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Prostatic Neoplasms; Brain Neoplasms; Central Nervous System Neoplasms; Head and Neck Neoplasms; Mesothelioma; Neoplasms; Adenocarcinoma of Lung; Skin Neoplasms; Salivary Gland Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma; Liver Neoplasms; Kidney Neoplasms Details
Erlotinib Hydrochloride CP-358774-01; RO-0508231; NSC-718781; CP-358774; RG-1415; OSI-774; R-1415 Approved Genentech Inc Tarceva, 特罗凯 Japan Carcinoma, Non-Small-Cell Lung Chugai Pharmaceutical Co Ltd 2004-11-18 Lung Neoplasms; Cholangitis, Sclerosing; Brain Neoplasms; Psoriasis; Cholangiocarcinoma; Prostatic Neoplasms; Breast Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Astrocytoma; Central Nervous System Neoplasms; Mouth Neoplasms; Leukemia, Myeloid, Acute; Brain metastases; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Adenocarcinoma; Hepatitis C, Chronic; Pancreatic Neoplasms; Leukemia, Promyelocytic, Acute; Solid tumours; Kidney Neoplasms; Ependymoma; Meningeal Carcinomatosis; Polycythemia Vera; Leukemia, Myelomonocytic, Acute; Myelodysplastic Syndromes; Head and Neck Neoplasms; Neoplasms; Glioblastoma; Leukemia, Myelomonocytic, Chronic; Adenocarcinoma of Lung; Skin Neoplasms; Urinary Bladder Neoplasms; Mesothelioma Details
Nimotuzumab OSAG-10; KI-0502; KI-0501; DE-766; YMB-1000; OSAG-101; h-R3; TheraCIMh-R3 Approved Center Of Molecular Immunology, Cimym Biosciences Theraloc, BIOMAb-EGFR, TheraCIM, 泰欣生, CIMAher Mainland China Nasopharyngeal Neoplasms Biotech Pharmaceuticals Co Ltd 2006-07-21 Transfer, Psychology; Esophageal Diseases; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Glioma; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Neoplasms; Nasopharyngeal Diseases; Pancreatic neuroendocrine tumors (pNET); Pancreatic Neoplasms; Nasopharyngeal Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Head and Neck Neoplasms Details
Lapatinib Ditosylate Hydrate GW-572016; GW-572016F; GW-2016 Approved Glaxosmithkline Plc, Novartis Pharma Ag Tykerb, Tyverb, 泰立沙, Tykerb/Tyverb Mainland China Breast Neoplasms Glaxosmithkline Ag 2007-03-13 Colorectal Neoplasms; Breast Neoplasms, Male; Neuroma, Acoustic; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Lung Neoplasms; Glioma; Carcinoma, Squamous Cell; Carcinoma, Ductal, Breast; Solid tumours; Prostatic Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; Neurofibromatosis 2; Neoplasms; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Stomach Neoplasms; Head and Neck Neoplasms Details
Brigatinib AP-26113 Approved Ariad, Takeda Pharmaceutical Co Ltd Alunbrig Mainland China Carcinoma, Non-Small-Cell Lung Takeda (China) International Trading Co Ltd 2017-04-28 Solid tumours; Ependymoma; Carcinoma; Neurofibromatosis 2; Neoplasms; Myofibroma; Granuloma, Plasma Cell; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Brain metastases; Carcinoma, Non-Small-Cell Lung; Meningioma; Neurilemmoma; Neuroma, Acoustic Details
Neratinib Maleate CAN-030; HKI-272; PF-0528767; WAY-179272; PB-272 Approved Pfizer Pharmaceuticals Ltd (China) Nerlynx, 贺俪安 Mainland China Breast Neoplasms Excella Gmbh & Co Kg 2017-07-17 Solid tumours; Leukemia; Triple Negative Breast Neoplasms; Glioblastoma; Neoplasms; Central Nervous System Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Hepatic Insufficiency; Lung Neoplasms; Lymphoma; Carcinoma, Non-Small-Cell Lung Details
Almonertinib Mesilate HS-10296 Approved Jiangsu Hansoh Pharmaceutical Group Co Ltd 阿美乐 Mainland China Carcinoma, Non-Small-Cell Lung Jiangsu Hansoh Pharmaceutical Group Co Ltd 2020-03-17 Neoplasms; Liver Diseases; Carcinoma, Adenosquamous; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Alflutinib Mesylate AST-2818 Approved Shanghai Allist Pharmaceutical Technology Co Ltd 艾弗沙 Mainland China Carcinoma, Non-Small-Cell Lung Shanghai Allist Pharmaceutical Technology Co Ltd 2021-03-02 Carcinoma, Bronchogenic; Bronchial Neoplasms; Thoracic Neoplasms; Adenocarcinoma of Lung; Respiratory Tract Diseases; Neoplasms; Lung Diseases; Respiratory Tract Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Osimertinib Mesylate AZD-9291 Mesylate; AZD9291; AZD-9291; RDL94R2A16 Approved Astrazeneca Pharmaceutical Co Ltd 泰瑞沙, Tagrisso Mainland China Carcinoma, Non-Small-Cell Lung Astrazeneca Ab 2015-11-13 Lung Diseases; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Brain metastases; Lung Neoplasms; Neoplasms, Nerve Tissue; Meningeal Neoplasms; Respiratory Tract Neoplasms; Solid tumours; Respiratory Tract Diseases; Neoplasms; Glioblastoma; Carcinoma; Bronchial Neoplasms; Thoracic Neoplasms; Carcinoma, Bronchogenic Details
Pyrotinib Maleate HTI-1001; SHR-1258; BLTN Approved Jiangsu Hengrui Medicine Co Ltd 艾瑞妮 Mainland China Breast Neoplasms Jiangsu Hengrui Medicine Co Ltd 2018-08-12 Solid tumours; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Adenocarcinoma of Lung; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Metastatic breast cancer; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Neoplasm Metastasis Details
Afatinib Dimaleate BIBW-2992; BIBW-2992-MA2 Approved C.H. Boehringer Sohn Ag & Co. Kg Gilotrif, Tomtovok, 吉泰瑞, Tovok, Giotrif Mainland China Carcinoma, Non-Small-Cell Lung Boehringer Ingelheim International Gmbh 2013-07-12 Breast Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Gallbladder Neoplasms; Esophageal Squamous Cell Carcinoma; Lymphoma, Non-Hodgkin; Uterine Neoplasms; Lung Neoplasms; Carcinoma, Squamous Cell; Ureteral Neoplasms; Colorectal Neoplasms; Urologic Neoplasms; Urethral Neoplasms; Brain Neoplasms; Head and Neck Neoplasms; Liver Diseases; Urinary Bladder Neoplasms; Multiple Myeloma; Chordoma; Endometriosis; Neuroectodermal Tumors; Neoplasms; Renal Insufficiency; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Rhabdomyosarcoma; Solid tumours Details
Cetuximab IMC-C255; BMS-564717; EMD-271786; C-255; GT-MAB-5.2; ch-225; LY-2939777; NSC-714692 Approved Bristol-Myers Squibb Company, Eli Lilly And Company, Merck Serono 爱必妥, Erbitux Mainland China Squamous Cell Carcinoma of Head and Neck Merck Serono Co Ltd 2004-02-12 Nasopharyngeal Carcinoma; Gastrointestinal Neoplasms; Neoplasm Metastasis; Carcinoma, Hepatocellular; Complex Regional Pain Syndromes; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma, Mucinous; Endometrial Neoplasms; Carcinoma, Squamous Cell; Laryngeal Neoplasms; Esophageal Squamous Cell Carcinoma; Neuralgia; Oropharyngeal Neoplasms; Colorectal Neoplasms; Liver Neoplasms; Sarcoma; Carcinoma, Adenoid Cystic; Nasopharyngeal Neoplasms; Neoplasms, Squamous Cell; Colonic Neoplasms; Hypopharyngeal Neoplasms; Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Humanized anti-EGFR monoclonal antibody (Hualan Biological Engineering/Henan shengming biotechnology) Phase 2 Clinical Henan Shengming Biotechnology Research Institute Co Ltd, Hualan Genetic Engineering Co Ltd Colorectal Neoplasms Details
ABY-029 ABY-029 Phase 1 Clinical Dartmouth College, Affibody, Li-Cor Bioscience Glioma Details
WTS-004 WTS-004 Phase 1 Clinical Hangzhou Wutong Tree Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
Anti-EGFR-IL-dox (Swiss Group for Clinical Cancer Research) Phase 2 Clinical Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung Breast Neoplasms Details
JRF-103 JRF103; JRF-103 Phase 2 Clinical Shenzhen Jinrui Foundation Biotechnology Co Ltd Solid tumours Details
XZP-5209 XZP-5209 Phase 1 Clinical Carcinoma, Non-Small-Cell Lung Details
Anti-CTLA-4/PD-1 expressing EGFR-CAR-T Phase 2 Clinical Shanghai Cell Therapy Research Institute Solid tumours Details
EGFR IL12 CART Phase 1 Clinical Shenzhen Prekin Biopharmaceutical Co Ltd Colorectal Neoplasms Details
Losatuxizumab vedotin ABBV221; ABBV-221 Phase 1 Clinical Abbvie Inc Neoplasms Details
E-EDV-D682 PNU-15982; E-EDV-D682; EGFR-EDV-PNU-15982 Phase 2 Clinical Engeneic Pancreatic Neoplasms Details
Serclutamab talirine ABBV-321 Phase 1 Clinical Abbvie Inc Neoplasms Details
Cetuximab biosimilar (Enzene Biosciences) Clinical Enzene Biosciences Ltd Carcinoma, Squamous Cell Details
Anti-EGFR CAR-T cell therapy (Cellular Biomedicine Group) Phase 2 Clinical Cellular Biomedicine (Shanghai) Co Ltd, People'S Liberation Army General Hospital Military Service Neoplasms Details
PB-357 PB-357 Phase 1 Clinical Pfizer Inc Neoplasms Details
SGT-210 SGT-210 Phase 1 Clinical Sol Gel Technologies Pte Ltd Keratosis Details
Cetuximab I-131 (Pacific Meinuoke) Clinical Jiangsu Pacific-Meinuoke Bio-Pharmaceutical Co Ltd Colorectal Neoplasms Details
KSP-QRH-E3-IRDye800 Phase 1 Clinical University Of Michigan Cholangiocarcinoma Details
Betatinib TL-512 Phase 1 Clinical Aspedia Llc, Suzhou Teligene Ltd Carcinoma, Non-Small-Cell Lung Details
DBPR-112 DBPR-112 Phase 1 Clinical National Health Research Institutes Head and Neck Neoplasms; Lung Neoplasms Details
Cetuximab biobetter (Mabtech/Sorrento) STI-001 Phase 3 Clinical Taizhou Maibo Taike Biotechnology Co Ltd, Shanghai Biomabs Pharmaceuticals Co Ltd Colorectal Neoplasms Details
EGFRvIII-CAR Phase 1 Clinical Duke University Medical Center Glioblastoma Details
Recombinant chimeric anti-EGFR monoclonal antibody (Qilu Pharmaceutical) QL-1105 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Solid tumours Details
Cetuximab biosimilar (Shanghai Henlius Biotech) HLX-05; JZB-29; JZB-28 Phase 1 Clinical Shanghai Henlius Biotech Co Ltd Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms Details
Double-deleted Vaccinia Virus Plus CD/ SMR JX-929; vvDD-CDSR Phase 1 Clinical Sillajen Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma Details
Cetuximab biosimilar (AlphaMab) KN-005 Phase 3 Clinical Suzhou Alphamab Co Ltd Head and Neck Neoplasms; Anus Neoplasms; Urinary Bladder Neoplasms; Colorectal Neoplasms Details
HER-1 vaccine (Center of Molecular Immunology) HER1-ECD; HER1-VSSP; HER-1-ECD-VSSP Phase 2 Clinical Center Of Molecular Immunology Neoplasms Details
Durvalumab/Gefitinib Phase 2 Clinical Medimmune Carcinoma, Non-Small-Cell Lung Details
Anti-EGFR CAR T-cell therapy (Seattle Children's Hospital) EGFR-806 Phase 1 Clinical Seattle Children'S Hospital Central Nervous System Neoplasms Details
Nimotuzumab biosimilar (IBC Generium) Phase 3 Clinical International Biotechnology Center Generium Llc Head and Neck Neoplasms Details
BC-3448 BC-3448; BC3448 Phase 1 Clinical Wuxi Zhikang Hongyi Biological Technology Co Ltd Solid tumours Details
FHND-9041 FHND-9041 Phase 3 Clinical Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
Recombinant anti-InE monoclonal antibody CmAb-(IL10)2 Phase 1 Clinical Dingfu Biotarget Co Ltd Solid tumours Details
BEBT-109 BEBT-109 Phase 2 Clinical Guangzhou BeBetter Medicine Technology Co Carcinoma, Non-Small-Cell Lung Details
SMET-12 SMET-12 Phase 1 Clinical Zhejiang Shimai Pharmaceutical Co Ltd Solid tumours Details
ES-072 ES-072 Phase 1 Clinical Zhejiang Bosheng Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
Sirotinib Maleate XZP-5491 Phase 1 Clinical Shandong Xuanzhu Pharmaceutical Technology Co Ltd Stomach Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung Details
Puvitinib Phase 1 Clinical Suzhou Teligene Ltd Solid tumours Details
KY-1701 KY-1701 Phase 1 Clinical Jiangsu Kanion Pharmaceutical Co Ltd Breast Neoplasms Details
Yinlitinib Phase 1 Clinical Hec Pharm Co Ltd Solid tumours Details
YK-029A YK-029A Phase 1 Clinical Hainan Yuekang Biomedicine Co Ltd Carcinoma, Non-Small-Cell Lung Details
Epertinib S-222611 Phase 2 Clinical Shionogi & Co Ltd Neoplasms Details
WSD-0922 WSD0922; WSD-0922 Phase 1 Clinical Vision Biological Tech (Hefei) Co Ltd Glioblastoma; Glioma Details
Mefatinib Phase 3 Clinical Suzhou Maitai Bio-Technology Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
YZJ-0318 Maleate YZJ-0318 Maleate Phase 1 Clinical Shanghai Haiyan Trading Co Ltd, Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
NIP-142 NIP-142 Phase 1 Clinical National Institutes Of Pharmaceutical Research And Development Co Ltd Carcinoma, Non-Small-Cell Lung Details
WJ-13404 WJ-13404; JS-113; WJ-004 Phase 1 Clinical Wigen Biomedicine technology (Shanghai) Co Ltd Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (AMPO Biotechnology) Phase 3 Clinical Ampo Biotechnology Inc Colorectal Neoplasms Details
Recombinant human anti-EGFR mAb (Serum Biotechnology) SY-101 Phase 2 Clinical Shanghai Serum Bio-Technology Co Ltd, Institute of Bioengineering Academy of Military Medical Sciences Chinese People's Liberation Army Solid tumours; Colorectal Neoplasms Details
H-002 H-002 Phase 2 Clinical Neoplasms; Carcinoma, Non-Small-Cell Lung Details
TAS-6417 CLN-081; TAS-6417 Phase 2 Clinical Taiho Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
CMAB-017 CMAB-017 Phase 1 Clinical Taizhou Mabtech Pharmaceutical Co Ltd Solid tumours Details
Rociletinib Hydrobromide CO-1686; AVL-301 Celgene Corp Details
Anti-CD3/anti-EGFR -activated T cells (Barbara Ann Karmanos Cancer Institute) Barbara Ann Karmanos Cancer Institute, University Of Virginia Details
XZP-5809-TT1 XZP-5809-TT1; XZP-5809 Phase 2 Clinical Shandong Xuanzhu Pharmaceutical Technology Co Ltd Carcinoma, Non-Small-Cell Lung Details
AEE-788 AEE-788; NVP-AEE-788 Novartis Pharma Ag Details
BMS-690514 BMS-690514 Bristol-Myers Squibb Company Details
Pirotinib Hydrochloride KBP-5209 Phase 2 Clinical Shandong Xuanzhu Pharmaceutical Technology Co Ltd Solid tumours; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Larotinib Mesylate Z-650 Phase 3 Clinical Guangdong Dongyangguang Pharmaceutical Co Ltd Solid tumours; Esophageal Neoplasms; Pancreatic Neoplasms; Esophageal Squamous Cell Carcinoma Details
ZZ-06 ZZ-06 Phase 1 Clinical Changchun Intellicrown Pharmaceutical Co Ltd Solid tumours Details
FCN-411 FCN-411 Phase 1 Clinical Shanghai Fosun Pharmaceutical (Group) Co Ltd Carcinoma, Non-Small-Cell Lung Details
REGN-7075 REGN-7075 Regeneron Pharmaceuticals Details
M-1231 M-1231 Emd Serono Research & Development Institute Inc, Merck Serono Details
ABBV-637 ABBV-637 Abbvie Inc Details
TY-9591 TY-9591 Phase 3 Clinical Zhejiang Tongkang Medicine Co Ltd Brain metastases; Carcinoma, Non-Small-Cell Lung Details
FWD1509 MsOH FWD1509 MsOH Phase 1 Clinical Shenzhen Forward Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
HS-10375 HS-10375 Phase 2 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Carcinoma, Non-Small-Cell Lung Details
[111In] Panitumumab Stanford University Details
BAY-2927088 BAY-2927088; BAY2927088 Phase 1 Clinical Bayer Healthcare Company Ltd, Bayer AG Carcinoma, Non-Small-Cell Lung Details
Anti-EGFR CAR-T cell therapy (Beijing Pregene) Phase 2 Clinical Shenzhen Prekin Biopharmaceutical Co Ltd Colorectal Neoplasms Details
Anti-EGFRvIII CAR T-cell therapy (Duke University Medical Center) Sanbo Brain Hospital Captial Medical University, Beijing Mali Biotechnology Co Ltd Details
CART-EGFR-IL13Ra2 CART-EGFR-IL13Ra2; CAR-T-EGFR-IL-13-Ra-2 Phase 1 Clinical University Of Pennsylvania Glioblastoma Details
BNA-035 BNA-035 Binacea Pharma Inc Details
BB-1705 BB-1705 Phase 1 Clinical Baili Sikang Biomedicine (Hangzhou) Co Ltd Solid tumours; Neoplasms; Neoplasm Metastasis Details
BLU-451 BLU-451 Blueprint Medicines Corp Details
EGFR/B7H3 CAR-T EGFR/B7H3 CAR-T Second Affiliated Hospital Of Guangzhou Medical University Details
DWP-708 DWP-708 Daewoong Pharmaceutical Co Ltd Details
Duligotuzumab RO-5541078; RG-7597; MEHD-7945A Genentech Inc Details
JMT101 JMT-101 Phase 3 Clinical Shanghai Jinmante Biological Technology Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
MicroRNA encapsulated nanocells (EnGeneIC) Engeneic Details
BDTX-1535 BDTX-1535 Black Diamond Therapeutics Glioblastoma Details
CX-904 CX-904 Amgen Inc, Cytomx Therapeutics Neoplasms Details
MP-412 AV-412; MP-412 Mitsubishi Tanabe Pharma Details
Sunvozertinib DZD-9008 Phase 2 Clinical Dizal (Jiangsu) Pharmaceutical Co Ltd Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung Details
Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian) CPGJ-602; 602; CPGJ602; CPGJ 602 Phase 2 Clinical Shanghai Cp Guojian Pharmaceutical Co Ltd Colorectal Neoplasms Details
ENN-01 ENN-01 Details
Bafisontamab FIT-013a; EMB-01 Phase 2 Clinical Shanghai Epimab Biotherapeutics, Inc Liver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
BDTX-189 BDTX-189 Black Diamond Therapeutics Details
AC-480 AC-480; BMS-599626 Bristol-Myers Squibb Company Details
Cimaglermin alfa CGF-2 Ludwig Institute For Cancer Research Details
Zalutumumab 2F8 Genmab Details
Autologous EGFR-CAR T cells (Bio-gene) Sun Yat-Sen University, Guangzhou Bio-Gene Technology Co Ltd Details
Demupitamab SCT-200 Phase 2 Clinical SinoCelltech Ltd Biliary Tract Neoplasms; Ovarian Neoplasms; Carcinoma; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Neoplasms; Colorectal Neoplasms; Gallbladder Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Agerafenib hydrochloride RXDX-105; AC013773; CEP-32496 Teva, Daiichi Sankyo Co Ltd, Ambit Biosciences, Cephalon Details
TAK-285 TAK-285 Takeda Details
Sym-013 Sym-013 Symphogen Details
MM-151 MM-151 Merrimack Details
LY-3164530 LY-3164530 Eli Lilly And Company Details
Immunomodulatory progenitor cell therapy (Celixir) Phase 3 Clinical Celixir Cardiomyopathies Details
Panitumumab-IRDye800CW (Stanford University) Stanford University Details
BB-101 (Blue Blood Biotech/National Cheng Kung University) BB-101 National Cheng Kung University, Blue Blood Biotech Corp Details
QL1203 QL-1203 Phase 3 Clinical Qilu Pharmaceutical Co Ltd Colorectal Neoplasms Details
Cetuximab biosimilar (R-Pharm) RPH-002 Phase 3 Clinical R-Pharm Head and Neck Neoplasms Details
Entinostat/Erlotinib Hydrochloride Colorado State University Foundation, Syndax Details
Nimotuzumab biosimilar (El Kendi Pharmaceuticals Manufacturing) El Kendi Pharmaceuticals Details
Tesevatinib XL-647; KD-020; KD-019; EXEL-7647 Exelixis Inc Details
[89Zr]Panitumumab (University of Alabama at Birmingham) University Of Alabama At Birmingham Details
TTI-1612 TTI-1612 Trillium Therapeutics Inc Details
TQB-3456 TQB-3456 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd Carcinoma, Non-Small-Cell Lung Details
Sapitinib AZD-8931 Astrazeneca Pharmaceutical Co Ltd Details
Tarloxotinib Bromide PR-610; TH-4000; SN-33999 Threshold Details
Anti-EGFR-bispecific antibody armed activated T-cell therapy (Memorial Sloan Kettering Cancer Center) Memorial Sloan Kettering Cancer Center Details
AFM-24 AFM-24 Affimed Details
C225-ILS-DOX C225-ILs-dox Phase 2 Clinical Universitaetsspitals Basel Breast Neoplasms Details
Antibody-drug nanocell conjugates (EnGeneIC) EGFR-EDV-RRM1; EGFR-EDV-PLK; EGFR-EDV-Dox Engeneic Details
PF-06459988 PF-6459988; PF-06459988 Pfizer Pharmaceuticals Ltd (China) Details
Kenaitinib MED-1007; TL-007 Phase 2 Clinical Jiangsu Maidu Pharmaceutical R & D Co Ltd Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Carcinoma, Non-Small-Cell Lung Details
EMD 55900 EMD-55900 Merck Serono Details
Imgatuzumab GA-201; R-7160; RG-7160; RO-5083945 Glycart Biotechnology Details
Rindopepimut ALT-110; CDX-110; SPX-110; PF-4948568; PF-4948569; PF-04948568; PF-04948569 Johns Hopkins University, Duke University Medical Center Details
JNJ-26483327 JNJ-26483327; MTKi-327; BGB-102 Johnson & Johnson Details
Mavelertinib PF-7775; PFE-X775; PF6747775; PF-06747775 Pfizer Pharmaceuticals Ltd (China) Details
MP-0274 DARPin-41; SPA-28; CME-114; CME-115; CME-118; CME-119; MP-0274 Molecular Partners Ag Details
MCLA-129 MCLA-129 Phase 2 Clinical Merus Solid tumours; Head and Neck Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Olafertinib CK-101; RX-518; CS-2481; EGFR-IN-3 Phase 3 Clinical Suzhou Neupharma Co Ltd Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (Shanghai Zhangjiang Biotechnology) STI-001; CMAB-009 Phase 3 Clinical Shanghai Zhangjiang Biotechnology Co Ltd Neoplasms; Colorectal Neoplasms Details
Petosemtamab MCLA-158 Merus Details
Sutetinib Maleate Phase 2 Clinical Jiangsu Maidu Pharmaceutical R & D Co Ltd, Jiangsu Suzhong Pharma Group Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
BPI-15086 BPI-15000; BPI-15086 Phase 1 Clinical Betta Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
D2C7-based immunotoxins (Duke University) D2C7-IT; scds-D2C7 -PE38KDEL; D2C7-(scdsFv)-PE38 KDEL Istari Oncology, Duke University Details
BBT-176 BBT-176 Bridge Biotherapeutics Details
Cetuximab biosimilar (Guilin Sanjin) CDP-1; BC-001 Phase 1 Clinical Dragonboat Biopharmaceutical, Guilin Sanjin Pharmaceutical Co Ltd Solid tumours; Colorectal Neoplasms Details
Depatuxizumab ch806; ABT-806; mAb-806 Ludwig Institute For Cancer Research Details
PLB-1004 PLB-1004 Phase 1 Clinical Beijing Anshi Biotechnology Co Ltd Carcinoma, Non-Small-Cell Lung Details
BPI-361175 BPI-361175 Phase 2 Clinical Betta Pharmaceuticals Co Ltd Carcinoma, Non-Small-Cell Lung Details
Cetuximab biosimilar (Kelun Group) KL-A140; KLA140; A-140; KL-140; KLA-140 Phase 3 Clinical Sichuan Kelun Pharmaceutical Co Ltd Colorectal Neoplasms Details
LR-004 LR-004; SYN-004 Phase 2 Clinical Lonn Ryonn Pharma Ltd Solid tumours; Carcinoma; Graft vs Host Disease; Lymphoma, Large B-Cell, Diffuse; Colorectal Neoplasms Details
Nazartinib EGF-816; EGFRmut-TKI EGF816 Phase 2 Clinical Novartis Pharma Ag Bronchial Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
GC-1118A GC-1118; GC-1118A Phase 2 Clinical Korean Green Cross Corp Solid tumours; Stomach Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis Details
HLX-35 HLX-35 Phase 1 Clinical Shanghai Henlius Biologics Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
TAK-186 EGFR x CD3 COBRA; MVC-101; TAK-186 Phase 2 Clinical Takeda Pharmaceutical Co Ltd Solid tumours; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
SKLB-1028 SKLB-1028 Phase 3 Clinical Sichuan University, CSPC Pharmaceutical Group Ltd Solid tumours; Leukemia, Promyelocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute Details
IAE-0972 IAE-0972 Phase 2 Clinical Shenghe (China) Biopharmaceutical Co Ltd Solid tumours Details
Futuximab/Modotuximab Sym-004; 992-and-1024 Phase 3 Clinical Symphogen Solid tumours; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Glioma Details
MRG003 MRG-003 Phase 2 Clinical Shanghai Miracogen Inc Head and Neck Neoplasms; Solid tumours; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Bile Duct Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BLU-945 BLU-945 Phase 2 Clinical Blueprint Medicines Carcinoma, Bronchogenic; Thoracic Neoplasms; Bronchial Neoplasms; Carcinoma; Respiratory Tract Diseases; Neoplasms; Lung Diseases; Respiratory Tract Neoplasms; Neoplasms, Nerve Tissue; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung Details
Recombinant anti-EGFR chimeric antibody (Harbin Pharmaceutical) Phase 1 Clinical Harbin Pharmaceutical Group Holding Co Ltd Colorectal Neoplasms Details
Cetuximab biosimilar (Humanwell Healthcare) Phase 1 Clinical Humanwell Healthcare (Group) Co Ltd Colorectal Neoplasms Details
Neptinib Di-P-methylbenzenesulfonate Phase 1 Clinical Shenzhen Neptunus Pharmaceutical Research Institute Co Ltd Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
LY-01010 LY-01010 Phase 1 Clinical Luye Pharma Group Ltd Breast Neoplasms Details
HS-10376 Phase 2 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Tomuzotuximab GT-MAB-5.2-GEX Phase 1 Clinical Glycotope Solid tumours; Squamous Cell Carcinoma of Head and Neck Details
Recombinant chimeric anti-EGFR monoclonal antibody (Zhejiang Xinwei Shengke Biotechnology) Phase 1 Clinical Zhejiang Xinweishengke Biotechnology Co Ltd Esophageal Neoplasms Details
JFAN-1001 JFAN-1001 Phase 2 Clinical Zhejiang Jianfeng Pharmaceutical Macutical Holdings Carcinoma, Non-Small-Cell Lung Details
NRC-2694 NRC-2694; NRC-2694A; NRC-2694-A Phase 2 Clinical Natco Carcinoma Details
Selatinib Ditosilate QLNC-120 Phase 2 Clinical Qilu Antibiotics (Linyi) Pharmaceutical Co Ltd, Qilu Pharmaceutical Co Ltd Breast Neoplasms Details
Doxitinib mesylate Phase 2 Clinical Henan Real Biotechnology Co Ltd Carcinoma, Non-Small-Cell Lung Details
Allitinib Tosylate AST-6; ALS-1306; AST-1306 Phase 2 Clinical Shanghai Allist Pharmaceutical Technology Co Ltd Breast Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Hemay-020 Hemay-020 Phase 1 Clinical Tianjin Hemay Pharmaceutical Co Ltd, Hainan General Sanyang Pharmaceutical Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
AMX-3009 Maleate AMX-3009; AMX3009马来酸 Phase 1 Clinical Anrun Medicine Technology (Suzhou) Co Ltd Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms Details
TQ-B3395 TQ-B3395; TQ-B-3395 Phase 1 Clinical Centaurus Biopharma Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Neoplasms; Breast Neoplasms Details
Simotinib Hydrochloride AL-6802; SIM-6802 Phase 1 Clinical Jiangsu Simcere Pharmaceutical Co Ltd, Advenchen Laboratories Carcinoma, Non-Small-Cell Lung Details
TQB3804 TQB-3804 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Solid tumours; Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung Details
BCA-101 BCA-101 Phase 1 Clinical Bicara Therapeutics Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Anus Neoplasms; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell Details
AP-L1898 JS111; AP-L1898; WJ-002 Phase 2 Clinical Suzhou Junjing Biomedical Technology Co Ltd, Wigen Biomedicine technology (Shanghai) Co Ltd, Shanghai Junshi Biosciences Co Ltd Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
BL-B01D1 Phase 1 Clinical Sichuan Baili Pharmaceutical Co Ltd Neoplasms, Fibroepithelial; Solid tumours; Neoplasms; Digestive System Neoplasms; Breast Neoplasms; Urologic Neoplasms; Gastrointestinal Neoplasms Details
BLU-701 BLU 701; BLU-701 Phase 2 Clinical Blueprint Medicines Carcinoma, Bronchogenic; Carcinoma; Thoracic Neoplasms; Bronchial Neoplasms; Respiratory Tract Diseases; Neoplasms; Lung Diseases; Respiratory Tract Neoplasms; Neoplasms, Nerve Tissue; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung Details
EG-007 EG-007 Phase 3 Clinical Evergreen Therapeutics Inc Endometrial Neoplasms Details
Pimurutamab HLX-07 Phase 2 Clinical Shanghai Henlius Biotech Co Ltd Solid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Adenosquamous; Colorectal Neoplasms; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Lazertinib GNS-1480; JNJ-1937; YH-25448; JNJ-73841937 Phase 3 Clinical Genosco Hepatic Insufficiency; Carcinoma, Non-Small-Cell Lung Details
Zorifertinib AZD-3759 Phase 3 Clinical Astrazeneca Plc Brain metastases; Carcinoma, Non-Small-Cell Lung Details
CKD-702 Phase 1 Clinical Chong Kun Dang Pharmaceutical Corp Carcinoma, Non-Small-Cell Lung Details
Izalontamab SI-B001; SI-1X6.4 Phase 3 Clinical Sichuan Baili Pharmaceutical Co Ltd Head and Neck Neoplasms; Solid tumours; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Triple Negative Breast Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung Details
ZSP-0391 ZSP-0391 Phase 1 Clinical Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd Carcinoma, Non-Small-Cell Lung Details
C-005 C-005 Phase 1 Clinical Nanjing Galaxy Biopharma Co Ltd Carcinoma, Non-Small-Cell Lung Details
HA121-28 HA121-28; SYHA121-28 Phase 3 Clinical CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd Biliary Tract Neoplasms; Solid tumours; Neoplasms; Medullary thyroid cancer (MTC); Bile Duct Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
GB-263 GB-263; GB-263T Phase 2 Clinical Genor Biopharma Co Ltd Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop